Newsfeeds Archive - Page 27 of 194

1 minute read

News

Novo Nordisk And Life Edit Therapeutics Established Multi-Target Collaboration To Discover And Develop Gene Editing Therapies For Rare And Cardiometabolic Diseases

May 24, 6:05 AM

Novo Nordisk and Life Edit Therapeutics, Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, today announced a research and development collaboration to discover and develop

NVO

1 minute read

Global Net Lease and The Necessity Retail REIT Late Tuesday Announced Merger Agreement; All-Stock Transaction

By Charles Gross

May 24, 5:40 AM

Global Net Lease Inc. (NYSE:GNL, ", , GNL", , )))) and The Necessity Retail REIT Inc. (NASDAQ:RTL, ", , RTL", , )))) announced today that they have entered into a definitive merger agreement (the

GNL

1 minute read

JinkoSolar’s Subsidiary Jiangxi Jinko Signed Equity Transfer Agreement For Disposal Of Its 100% Equity Interest In Xinjiang Jinko

By Charles Gross

May 24, 5:02 AM

- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its majority-owned

JKS

1 minute read

News
Tech

Applied Materials Expects To Investment Up To $4B Over Next Seven Years For R&D Center In Silicon Valley

By Charles Gross

May 22, 5:04 AM

Applied Materials, Inc. today announced a landmark investment to build the world's largest and most advanced facility for collaborative semiconductor process technology and manufacturing equipment research and

AMAT

1 minute read

Lucid Earlier Announced European Pricing for Lucid Air Pure AWD and Lucid Air Touring

By Charles Gross

May 22, 4:51 AM

Lucid Group, Inc. (NASDAQ:LCID), setting new standards for luxury electric experience with the Lucid Air, winner of the 2023 World Luxury Car Award, today announced European pricing for the Lucid Air Pure AWD and

LCID

1 minute read

Immunic Announced That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

By Charles Gross

May 17, 6:34 AM

Immunic, Inc.

IMUX

1 minute read

OneSpaWorld Late Tuesday Priced 9M Share Offering of Common Shares by Selling Shareholders @$10/Share

By Charles Gross

May 17, 5:24 AM

OneSpaWorld Holdings Limited (NASDAQ: OSW) ("OneSpaWorld" or the "Company"), the preeminent global provider of health and wellness services and products onboard cruise ships and in destination resorts around the world, today announced the pricing of its previously announced underwritten secondary offering of common shares of th

OSW

1 minute read

News

Immatics Biotechnologies Granted U.S. Patent #11648276: Immunotherapy against neuronal and brain tumors; #11648292: Immunotherapy against several tumors including gastrointestinal and gastric cancer

By Charles Gross

May 16, 7:40 AM

US 11648276 B2 Abstract The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of

IMTX

1 minute read

FDA
News

Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alpha in Non-Small Cell Lung Cancer

By Charles Gross

May 15, 7:42 PM

Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces

IMMP

1 minute read

News

Lithium Americas Board Approved Agreement Providing for Separation into Two Leading Lithium Companies

By Charles Gross

May 15, 5:53 PM

Lithium Americas Corp. (TSX:LAC) (NYSE:LAC) ("Lithium Americas" or the "Company") is pleased to announce that its Board of Directors has unanimously approved the execution of an arrangement agreement

LAC